Lin Yi-chu
Lin Yi-chu is the deputy head of the Medicinal Product Division of Taiwan's Food and Drug Administration (FDA). She recently spoke at a news conference regarding the FDA's initiative to consider allowing over-the-counter sales of morning-after pills in Taiwan, following a regulatory experiment in Japan.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Taiwan | 1 | 5.00 | 0.13% | +0% | 23,816,775 | 32,012 | $670,000 | 901$ |
| Totals | 1 | 23,816,775 | 32,012 | $670,000 | 901$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Taiwan:
Lin Yi-chu, deputy head of the Medicinal Product Division, discussed the prohibition of fenfluramine in Taiwan.
5
Taiwan:
Lin Yi-chu, deputy head of the Medicinal Product Division, discussed the FDA's proposal for over-the-counter sale of morning-after pills.
7